Beta2 and Alpha2 adrenergic receptors mediate the proneurogenic in vitro effects of norquetiapine

Keyphrases

• In Vitro Effect 100%
• Norquetiapine 100%
• β2-Adrenergic Receptor (β2AR) 100%
• α2-adrenergic Receptor 100%
• Quetiapine 66%
• Antidepressants 50%
• Adult Hippocampal Neurogenesis 33%
• Selective Antagonist 16%
• High Affinity 16%
• Adult Neurogenesis 16%
• Therapeutic Effect 16%
• Receptor Profile 16%
• Neural Stem Cells 16%
• Therapeutic Potential 16%
• Clinically Significant 16%
• Atypical Antipsychotics 16%
• Serotonin-norepinephrine Reuptake Inhibitors 16%
• Parent Compounds 16%
• Antipsychotics 16%
• Active Metabolite 16%
• Distinctive Properties 16%
• Norepinephrine Transporter 16%

Neuroscience

• In Vitro 100%
• Quetiapine 100%
• Beta-2 Adrenergic Receptor 100%
• Alpha-2 Adrenergic Receptor 100%
• Neurogenesis 75%
• Antidepressant 50%
• Norepinephrine Transporter 50%
• Receptor 50%
• Antidepressant 25%
• Neural Stem Cell 25%
• Atypical Antipsychotic 25%
• Antipsychotic 25%

Pharmacology, Toxicology and Pharmaceutical Science

• Quetiapine 100%
• Beta 2 Adrenergic Receptor 100%
• Alpha 2 Adrenergic Receptor 100%
• Receptor 50%
• Antidepressant 50%
• Noradrenalin Transporter 50%
• Antidepressant 25%
• Atypical Antipsychotics 25%
• Preclinical Study 25%
• Antipsychotic 25%
• Therapeutic Effect 25%
• Active Metabolite 25%